Evidence map›Paper›PMID 33963865›Full record

ArticleSchizophrenia bulletin2021

Duration of Untreated Psychosis in First-Episode Psychosis is not Associated With Common Genetic Variants for Major Psychiatric Conditions: Results From the Multi-Center EU-GEI Study.

Olesya Ajnakina, Victoria Rodriguez, Diego Quattrone, Marta di Forti, Evangelos Vassos, Celso Arango, Domenico Berardi, Miguel Bernardo, Julio Bobes, Lieuwe de Haan and 25 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Schizophrenia bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 20 institutions in 8 countries.

Olesya AjnakinaDepartment of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, University of London, London, UK.ORCID 0000-0003-3987-1236
Victoria RodriguezDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Diego QuattroneSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Marta di FortiSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Evangelos VassosSocial, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID 0000-0001-6363-0438
Celso ArangoChild and Adolescent Psychiatry Department, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, Madrid, Spain.
Domenico BerardiDepartment of Biomedical and Neuromotor Sciences, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Bologna, Italy.
Miguel BernardoDepartment of Psychiatry, Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
Julio BobesFaculty of Medicine and Health Sciences - Psychiatry, Universidad de Oviedo, ISPA, INEUROPA, CIBERSAM, Oviedo, Spain.
Lieuwe de HaanDepartment of Psychiatry, Early Psychosis Section, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Cristina Marta Del-BenNeuroscience and Behavior Department, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
Charlotte Gayer-AndersonDepartment of Health Service and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, UK.
Hannah E JongsmaCentre for Longitudinal Studies, University College London, London, UK.
Antonio LasalviaSection of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Sarah TosatoSection of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Pierre-Michel LlorcaUniversité Clermont Auvergne, CMP-B CHU, CNRS, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand, France.
Paulo Rossi MenezesDepartment of Preventative Medicine, Faculdade de Medicina FMUSP, University of São Paulo, São Paulo, Brazil.
Bart P RuttenDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, Maastricht, The Netherlands.
Jose Luis SantosDepartment of Psychiatry, Servicio de Psiquiatría Hospital "Virgen de la Luz," Cuenca, Spain.
Julio SanjuánDepartment of Psychiatry, Hospital Clínico Universitario de Valencia, INCLIVA, CIBERSAM, School of Medicine, Universidad de Valencia, Valencia, Spain.
Jean-Paul SeltenRivierduinen Institute for Mental Health Care, Sandifortdreef 19, 2333 ZZ Leiden, The Netherlands.
Andrei SzökeUniv Paris Est Creteil, INSERM, IMRB, AP-HP, Hôpitaux Universitaires " H. Mondor ," DMU IMPACT, Fondation FondaMental, Creteil, France.
Ilaria TarriconeDivision of Psychological Medicine and Clinical Neurosciences, Cardiff, UK.
Giuseppe D'AndreaDepartment of Biomedical and Neuromotor Sciences, Psychiatry Unit, Alma Mater Studiorum Università di Bologna, Bologna, Italy.
Alexander RichardsDivision of Psychological Medicine and Clinical Neurosciences, Cardiff, UK.ORCID 0000-0003-3218-7247
Andrea TortelliEtablissement Public de Santé Maison Blanche, Paris, France.
Eva VelthorstDepartment of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Peter B JonesDepartment of Psychiatry, University of Cambridge, Herchel Smith Building for Brain & Mind Sciences, Cambridge, UK.
Manuel Arrojo RomeroDepartment of Psychiatry, Psychiatric Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Caterina La CasciaDepartment of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, Palermo, Italy.
James B KirkbridePsylife Group, Division of Psychiatry, University College London, London, UK.ORCID 0000-0003-3401-0824
Jim van OsDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Mick O'DonovanDivision of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
Robin M MurrayDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
EU-GEI WP2 Group
King's College London · GBCardiff University · GBUniversidade de São Paulo · BRUniversity of Bologna · ITUniversity of Verona · ITAmsterdam University Medical Centers · NLCentre National de la Recherche Scientifique · FRComplejo Hospitalario Universitario de Santiago · ESGGZ Rivierduinen · NLHospital Clínic de Barcelona · ESHospital General Universitario Gregorio Marañón · ESHospital Virgen de la Luz · ESInserm · FRMaastricht University Medical Centre · NLUniversidad de Oviedo · ESUniversitat de València · ESUniversity College London · GBUniversity Medical Center Groningen · NLUniversity of Amsterdam · NLUniversity of Cambridge · GB

Funding

Department of Health PDF-2018-11-ST2-020Medical Research Council MR/L010305/1Medical Research Council MR/M008436/1
6 · The paper itself

Abstract

Duration of untreated psychosis (DUP) is associated with clinical outcomes in people with a diagnosis of first-episode psychosis (FEP), but factors associated with length of DUP are still poorly understood. Aiming to obtain insights into the possible biological impact on DUP, we report genetic analyses of a large multi-center phenotypically well-defined sample encompassing individuals with a diagnosis of FEP recruited from 6 countries spanning 17 research sites, as part of the European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) study. Genetic propensity was measured using polygenic scores for schizophrenia (SZ-PGS), bipolar disorder (BD-PGS), major depressive disorder (MDD-PGS), and intelligence (IQ-PGS), which were calculated based on the results from the most recent genome-wide association meta-analyses. Following imputation for missing data and log transformation of DUP to handle skewedness, the association between DUP and polygenic scores (PGS), adjusting for important confounders, was investigated with multivariable linear regression models. The sample comprised 619 individuals with a diagnosis of FEP disorders with a median age at first contact of 29.0 years (interquartile range [IQR] = 22.0-38.0). The median length of DUP in the sample was 10.1 weeks (IQR = 3.8-30.8). One SD increases in SZ-PGS, BD-PGS, MDD-PGS or IQ-PGS were not significantly associated with the length of DUP. Our results suggest that genetic variation does not contribute to the DUP in patients with a diagnosis of FEP disorders.

Indexed as

Genome-Wide Association StudyAdultBipolar DisorderBrazilCase-Control StudiesEuropeHumansIntelligenceMajor Depressive DisorderPsychotic DisordersSchizophreniaTime Factorsduration of untreated psychosisgenome-wide association studiespolygenic scorespsychosisschizophrenia

Identifiers

PMID33963865
PMCPMC8562562
OpenAlexW3157082332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.